Empfehlungen zur systemischen Therapie des metastasierten Nierenzellkarzinoms 2019

Translated title of the contribution: Current recommendations for the systemic treatment of metastatic renal cell carcinoma

Nils Kröger, Axel S. Merseburger, Jens Bedke

2 Citations (Scopus)

Abstract

Numerous substances are available for the treatment of metastatic renal cell carcinoma (mRCC). Therefore, medical treatment of patients with mRCC has become a very complex subject. This review summarises clinical studies and typical side-effects of currently available agents that have been approved in Germany. The authors give suggestions for the use of these substances in the different therapy lines.

Translated title of the contributionCurrent recommendations for the systemic treatment of metastatic renal cell carcinoma
Original languageGerman
JournalAktuelle Urologie
Volume50
Issue number6
Pages (from-to)606-611
Number of pages6
ISSN0001-7868
DOIs
Publication statusPublished - 04.09.2019

Research Areas and Centers

  • Research Area: Luebeck Integrated Oncology Network (LION)

Fingerprint

Dive into the research topics of 'Current recommendations for the systemic treatment of metastatic renal cell carcinoma'. Together they form a unique fingerprint.

Cite this